Want to join the conversation?
Derik de Bruin of BofA ML asks about capital deployment. CEO Tom Joyce replied that $DHR's bias towards M&A is not specifically skewed towards any of its four segments. Tom added that the company has had a consistent track record of capital allocation across each of those four segments that it will be reporting on in the future.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?